doi: 10.1038/nrrheum.2010.196 40 ZhaoYWangCYangTWangHZhaoSSunNet al
There are two distinct versions: CJC1295 with DAC Drug Affinity Complex extends the half-life to ~8 days, allowing weekly injections , but lacks pulsatility CJC1295 without DAC Shorter half-life (~30 minutes), ideal for physiological GH pulses , and preferred in performance enhancement settings For athletic performance and recovery, CJC1295 without DAC is most often chosen due to its compatibility with GHRP2 , MK677 , and BPC157
At-home roller depth is typically 0.5 to 1.0 mm
The SURMOUNT-4 trial demonstrated that participants who achieved significant weight loss on tirzepatide and then continued treatment maintained their weight loss, while those switched to placebo regained substantial weight
The Journal of Clinical Pharmacology, 2018
Liu M, Fang X, Yang Y, Wang C